Veeva Systems convenes global pharmaceutical leaders in Boston to demonstrate AI-powered software designed to streamline drug development, clinical trials, and quality manufacturing workflows.
Veeva Systems is positioning itself as a central technology partner for major pharmaceutical firms by hosting its R&D and Quality Summit. The event highlights how industry leaders like Eli Lilly, Pfizer, and Sanofi are utilizing Veeva's platform to accelerate drug development, integrate clinical trials, and modernize manufacturing processes, thereby strengthening the company's competitive moat in the life sciences software sector.
The summit focuses on sharing learnings regarding speeding up drug development, connecting clinical trials, and modernizing quality and manufacturing processes.
Participants include Eli Lilly and Company, Pfizer, Sanofi, and UCB.
Eli Lilly is participating in the Veeva Summit to share learnings on speeding drug development, indicating ongoing collaboration but no direct financial impact.
Pfizer is mentioned as a participant sharing learnings at the Veeva Summit, reflecting routine industry engagement without material financial implications.
Sanofi is listed as a participant at the Veeva Summit to share learnings on modernizing quality and manufacturing, with no direct financial impact.
UCB is mentioned as a participant sharing learnings at the Veeva Summit, indicating industry collaboration but no material financial event.
Veeva Systems hosts its annual R&D and Quality Summit in Boston, highlighting new AI-driven software solutions for the life sciences sector. Industry leaders including Eli Lilly, Pfizer, Sanofi, and UCB will present case studies on accelerating drug development and modernizing manufacturing processes through digital integration.
The summit focuses on showcasing AI innovations and digital strategies to accelerate drug development, connect clinical trials, and modernize manufacturing and quality processes.
Participants include Eli Lilly, Pfizer, Sanofi, and UCB, who are sharing insights on their operational improvements.